Editorial Policies

Aims and Scope

Magazine 'Cytokines and Inflammation' is the Russia's first periodical devoted solely and specifically the issue of cytokines and inflammation in all its aspects and intended for general practitioners, allergists, immunologists, pulmonologists, rheumatologists, gastroenterologists, students. The journal publishes materials devoted to theoretical and practical aspects of studying cytokines, cytokine application in medical practice, the mechanisms of inflammatory and immune responses, mechanisms of action of anti-inflammatory and immunomodulatory drugs and new developments in the field of inflammation chemotherapy.

Cytokines (interleukins, chemokines, lymphokines, monokines, interferons) are important factors regulating protective human response, including inflammatory and immune reactions, and are among the most actively investigated biologically active molecules.

Inflammation is the basis of defense reactions and immunity. It is a huge health problem, being the cornerstone of many types of pathology (infection, tumor, hepatitis, tuberculosis, immune deficiency, atherosclerosis). The problem of inflammation has been and remains urgent, bringing together physicians, clinicians and research scientists of almost all profiles. So far, none of the Russian periodicals is not specialized in the coverage of a multi-faceted, "multidisciplinary" problem of inflammation in its entirety.

Cytokines and Inflammation journal is published since 2002. It is indexed by the Russian Abstract Journals, VINITI databases, Ulrichs Periodicals Directory.

Sections

Original Study Article

Reviews

Lectures

Practitioner Advisor

Brief communications

Immunology in clinics and universities

Science News in Brief

Chronicle

Jubilees

Advertisement

Editorial

Book reviews

Indices

Announcements

Conferences, symposia

New in laboratory diagnostics

New bioresearch technologies

Peer Review Process

Procedure for selection articles to be published in the journal Cytokines and Inflammation.

1. All manuscripts of scientific articles submitted to the Editorial Board of the Journal are peer-reviewed according to the approved procedure.
2. The Editorial Board of the Journal establishes the conformity of the manuscript to the profile of the Journal, requirements to the design and sends it for the first review to the responsible secretary of the Journal, who determines the scientific value of the manuscript and appoints reviewers. Articles are reviewed by members of the Editorial Board of the Journal, as well as by external reviewers from among the leading specialists in the field, working in the scientific areas corresponding to the topic of the article.
3. The review is conducted confidentially, in a "double-blind" mode. The author of the reviewed article is given an opportunity to read the texts of reviews after each round of reviewing.
4. The review period for each round is 3 weeks. At the request of reviewers, the review period can be extended.
5. In order to obtain the most complete and objective feedback on the article, the editorial office has developed a memo to the reviewer with a list of issues whose coverage in the article the reviewer should evaluate. On the basis of this evaluation, the reviewer makes his/her conclusion about the further fate of the article:
• article recommended for publication
• (a) As presently constituted;
• b) taking into account the correction of deficiencies noted by the reviewer;
• the article is recommended to be submitted to another specialist for additional review;
• the article is not recommended for publication.
6. If the review contains recommendations for correction and revision of the article, the Editorial Director of the journal sends the author the text of the review with a proposal to take them into account in the preparation of a new version of the article or to refute them (partially or completely) with arguments. The article revised by the author is sent for review again.
7. If the author and the reviewer have irresolvable contradictions regarding the article, the editorial board has the right to send the article to another reviewer. In conflict situations, the article may be submitted to one of the members of the Editorial Board for consideration; the final decision in such cases is made by the Editor-in-Chief.
8. The article not recommended for publication by the reviewer is not accepted for reconsideration. Notification of the negative decision of the Editorial Board and Editor-in-Chief regarding the possibility of publication of the work is sent to the author by e-mail.
9. The presence of a positive review is not a sufficient basis for publication of the article. The final decision on the expediency of publication is made by the editorial board based on the validity of the work and its compliance with the subject of the journal. In conflict situations, the decision is made by the Editor-in-Chief. The decision of the editorial board on each article is recorded in the minutes of the editorial board meeting.
10. The original reviews are kept in the editorial office of the journal for at least three years.
11. The reviewer should adhere to the following questions when evaluating the article and writing the review:
• Originality of the work, novelty of the data obtained
• Completeness and correctness of the problem presentation in the literature review
• Relevance of the topicThe relevance of the article to the current state of the issue under study
• Clarity of the goals and objectives of the work, their correspondence to the presented factual material
• Details of the description of materials and methodsAdequacy of the choice of research methods
• Adequacy of statistical analysis
• Relevance of the results to the objectives of the study
• Availability of evaluation of the data obtained
• Reasonableness of conclusions
• Scientific significance of the results of the work
• Practical significance of the results of the work
• Visibility of material presentation (availability of tables, figures)
• Existence of comparison of own data with literature data
• Availability of references to all relevant publications on the topic of work
• Quality and length of the summary
• Compliance of work with ethical standards

Publication Frequency

Number of issues per year: 4

Archiving

The journal uses the PKP Preservation Network (PKP PN) to digitally preserve all the published articles. The PKP PN is a part of LOCKSS (Lots of Copies Keep Stuff Safe) program offers decentralized and distributed preservation, seamless perpetual access, and preservation of the authentic original version of the content.

Also, the journal makes full-text archives on the Russian Science Electronic Library (http://elibrary.ru/) platform.

Author Self-Archiving

The journal is compliant with Green Open Access mode (formerly known as Open Self-Archiving) for articles distribution.

Delayed Open Access

The contents of this journal will be available in an open access format 24 month(s) after an issue is published.

Issue Purchase

Readers without a subscription may still purchase individual issues. The following payment options and fees are available.

Access for an Issue: 466.00 (USD)

You can purchase the access for all articles published in one issue. Access to articles will be provide for an unlimited time.

Access to issue allows you to read, download and print full text (PDF and HTML) of all articles, but does not allow to distribute, copy or reproduce articles materials until the end of the embargo period (3 years) since the publication of the article).

Article Purchase

Readers without a subscription may still purchase individual articles. The following payment options and fees are available.

Access for an Article: 35.00 (USD)

You can purchase the access for the article to read, download and print its fulltext (PDF, HTML). Access to article will be provide for an unlimited time.

Purchased access does not allow to distribute, copy or reproduce article's materials until the end of the embargo period (3 years) since the publication of the article).

Indexing

The journal is indexed in:

• Russian Science Citation Index
• VINITI
• Ulrich's Periodical Directory
• CrossRef
• Dimensions
• Google Scholar

Publishing Ethics

The Ethic policy of "Cytokines and inflammation" journal is based on recomendations from international commettees:

• ICMJE — The International Committee of MEDICAL JOURNAL EDITORS http://www.icmje.org/
• WAME — The WORLD ASSOCIATION OF MEDICAL EDITORS http://www.wame.org/
• COPE — Committee on Publication Ethics http://publicationethics.org/
• ORI — The office of Research Integrity http://ori.hhs.gov/
• CSE — Council of Science Editors http://www.councilscienceeditors.org/
• EASE — European Association of Science Editors http://www.ease.org.uk/

Reporting standarts

The Cytokines and inflammation journal editorial team ask authors of reports of original research to present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.

Review and professional publication articles should also be accurate and objective, and editorial opinion works should be clearly identified as such.

Data Access and Retention

Authors may be asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.

Authorship clarified

The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before the work is submitted.

The Publisher does not prescribe the kinds of contributions that warrant authorship. It is recommended that authors adhere to the guidelines for authorship that are applicable in their specific research field. In absence of specific guidelines it is recommended to adhere to the following guidelines (based on ICMJE guidelines):

All authors whose names appear on the submission:

1. made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work AND
2. drafted the work or revised it critically for important intellectual content AND
3. approved the version to be published AND
4. agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Anyone who contributed to the research or manuscript preparation, but is not an author, should be acknowledged with their permission.

Submissions by anyone other than one of the authors will not be considered.

Research Ethics and Patient Consent (Statement of Human and Animal Rights)

Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.

Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please do not submit the patient’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file.

Please also refer to the ICMJE Recommendations for the Protection of Research Participants.

Hazards for Human or Animal Subjects

If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript. If the work involves the use of animal or human subjects, the authors should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) have approved them. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.

When reporting experiments on animals, authors have to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.

Research involving human embryos, gametes, and stem cells

Manuscripts that report experiments involving the use of human embryos and gametes, human embryonic stem cells and related materials, and clinical applications of stem cells must include confirmation that all experiments were performed in accordance with relevant guidelines and regulations (See also Research involving human participants and/or animals)

The manuscript should include an ethics statement identifying the institutional and/or national research ethics committee (including the name of the ethics committee) approving the experiments and describing any relevant details. Authors should confirm that informed consent (See also Informed consent) was obtained from all recipients and/or donors of cells or tissues, where necessary, and describe the conditions of donation of materials for research, such as human embryos or gametes. Copies of approval and redacted consent documents may be requested by the Journal.

We encourage authors to follow the principles laid out in the 2016 ISSCR Guidelines for Stem Cell Research and Clinical Translation.

In deciding whether to publish papers describing modifications of the human germline, the Journal is guided by safety considerations, compliance with applicable regulations, as well as the status of the societal debate on the implications of such modifications for future generations. In case of concerns regarding a particular type of study the Journal may seek the advice from the Springer Nature Research Integrity Group.

The decision to publish a paper is the responsibility of the Editor-in-Chief of the Journal.

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Articles should make no assumptions about the beliefs or commitments of any reader, should contain nothing which might imply that one individual is superior to another on the grounds of race, sex, culture or any other characteristic, and should use inclusive language throughout. Authors should ensure that writing is free from bias, for instance by using 'he or she', 'his/her' instead of 'he' or 'his', and by making use of job titles that are free of stereotyping (e.g. 'chairperson' instead of 'chairman' and 'flight attendant' instead of 'stewardess').

Conflicts of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.

Conflicts include the following:

• Financial — funding and other payments, goods and services received or expected by the authors relating to the subject of the work or from an organization with an interest in the outcome of the work;
• Affiliations — being employed by, on the advisory board for, or a member of an organization with an interest in the outcome of the work;
• Intellectual property — patents or trademarks owned by someone or their organization;
• Personal — friends, family, relationships, and other close personal connections;
• Ideology — beliefs or activism, for example, political or religious, relevant to the work;
• Academic — competitors or someone whose work is critiqued.

For more information on conflicts of interest, see the guidance from the ICMJE and WAME.

Funding and Acknowledgement of Sources

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://www.crossref.org/services/funder-registry/  

Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work. Information obtained privately, as in conversation, correspondence, or discussion with third parties, must not be used or reported without explicit, written permission from the source. Information obtained in the course of confidential services, such as refereeing manuscripts or grant applications, must not be used without the explicit written permission of the author of the work involved in these services.

Plagiarism

Plagiarism takes many forms, from passing off another paper as the author(s) own paper, to copying or paraphrasing substantial parts of another(s) paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable. Only original works are acceptable for publication in "Cytokines and inflammation" journal. The journal does not allow any forms of plagiarism. Authors must not use the words, figures, or ideas of others without attribution. All sources must be cited at Cytokines and inflammation journal take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. All the submitted articles are evaluated with plagiarism-checking software (Antiplagiat). Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgment, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to:

• publishing an erratum or corrigendum (correction);
• retracting the article;
• taking up the matter with the head of department or dean of the author’s institution and/or relevant academic bodies or societies;
• or taking appropriate legal action.

Also you can see ORI Avoiding Plagiarism, Self-plagiarism, and Other Questionable Writing Practices: A Guide to Ethical Writing

Duplicate Submission and Redundant Publication

Cytokines and inflammation journal consider only original content, i.e. articles that have not been previously published, including in a language other than English. Articles based on content previously made public only on a preprint server, institutional repository, or in a thesis will be considered.

Manuscripts submitted to Cytokines and inflammation journal must not be submitted elsewhere while under consideration and must be withdrawn before being submitted elsewhere. Authors whose articles are found to have been simultaneously submitted elsewhere may incur sanctions.

If authors have used their own previously published work, or work that is currently under review, as the basis for a submitted manuscript, they must cite the previous articles and indicate how their submitted manuscript differs from their previous work. Reuse of the authors’ own words outside the Methods should be attributed or quoted in the text. Reuse of the authors’ own figures or substantial amounts of wording may require permission from the copyright holder and the authors are responsible for obtaining this.

Cytokines and inflammation journal will consider extended versions of articles published at conferences provided this is declared in the cover letter, the previous version is clearly cited and discussed, there is significant new content, and any necessary permissions are obtained.

Redundant publication, the inappropriate division of study outcomes into more than one article (also known as salami slicing), may result in rejection or a request to merge submitted manuscripts, and the correction of published articles. Duplicate publication of the same, or a very similar, article may result in the retraction of the later article and the authors may incur sanctions.

Citation Manipulation

Authors whose submitted manuscripts are found to include citations whose primary purpose is to increase the number of citations to a given author’s work, or to articles published in a particular journal, may incur sanctions.

Editors and reviewers must not ask authors to include references merely to increase citations to their own or an associate’s work, to the journal, or to another journal they are associated with.

Fundamental errors in published works, Corrections and Retractions

When an author discovers a significant error or inaccuracy in his/her own published work, it is the authors obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.

If the editor or the publisher learn from a third party that a published work contains a significant error, it is the obligation of the author to promptly retract or correct the paper or provide evidence to the editor of the correctness of the original paper.

When errors are identified in published articles, the publisher will consider what action is required and may consult the editors and the authors’ institution(s). 

Errors by the authors may be corrected by a corrigendum, and errors by the publisher — by an erratum (see more).

If there are errors that significantly affect the conclusions or there is evidence of misconduct, this may require retraction or an expression of concern following the COPE Retraction Guidelines. All authors will be asked to agree to the content of the appropriate notice.

Sanctions

If Cytokines and inflammation journal becomes aware of breaches of our publication ethics policies, the following sanctions may be applied:

• Rejection of the manuscript and any other manuscripts submitted by the author(s).
• Not allowing submission for 1–3 years.
• Prohibition from acting as an editor or reviewer.

Cytokines and inflammation journal may apply additional sanctions for severe ethical violations.